PREVALENCE OF CARDIOVASCULAR DISEASE BY VASCULAR BED IN TYPE 2 DIABETES POPULATION IN A REAL-WORLD SETTING

被引：0
|
作者：
Weng, Wayne [1 ]
Kong, Sheldon [1 ]
Ganguly, Rahul [1 ]
Hersloev, Malene [1 ]
Brett, Jason [1 ]
Hobbs, Todd [1 ]
Baeres, Florian M. M. [1 ]
机构：
[1] Novo Nordisk Inc, Plainsboro, NJ USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)32365-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-413
引用
收藏
页码：1759 / 1759
页数：1
相关论文
共 50 条
  • [21] Introduction: Real-World Evidence in Type 2 Diabetes
    Mohamed Hassanein
    Aslam Amod
    Kamlesh Khunti
    Moon-Kyu Lee
    Viswanathan Mohan
    Diabetes Therapy, 2020, 11 : 29 - 32
  • [22] Metformin dosage patterns in type 2 diabetes patients in a real-world setting in the United States
    Mahabaleshwarkar, Rohan
    DeSantis, Andrea
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 172
  • [23] First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
    Tsai, Shih-Tzer
    Pathan, Faruque
    Ji, Linong
    Yeung, Vincent Tok Fai
    Chadha, Manoj
    Suastika, Ketut
    Son, Hyun Shik
    Tan, Kevin Eng Kiat
    Benjasuratwong, Yupin
    Thy Khue Nguyen
    Iqbal, Farrukh
    JOURNAL OF DIABETES, 2011, 3 (03) : 208 - 216
  • [24] Consequences of Nonmedical Switch among Patients on Type 2 Diabetes Medications in a Real-World Setting
    Flores, Natalia M.
    Patel, Charmi A.
    Bookhart, Brahim K.
    Bacchus, Shaffeeulah
    DIABETES, 2017, 66 : A361 - A361
  • [25] Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population
    Donnelly, Louise A.
    McCrimmon, Rory J.
    Pearson, Ewan R.
    DIABETOLOGIA, 2024, 67 (10) : 2236 - 2245
  • [26] Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
    Kang, Shinae
    Ahn, Yu-Bae
    Oh, Tae Keun
    Lee, Won-Young
    Chun, Sung Wan
    Bae, Boram
    Dahaoui, Amine
    Jeong, Jin Sook
    Jung, Sungeun
    Jang, Hak Chul
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [27] SGLT2 Inhibitors Are Associated With Reduced Cardiovascular Disease in Patients With Type 2 Diabetes: An Analysis of Real-World Data
    Wang, Wendy
    Chen, Lin Yee
    Walker, Rob F.
    Chow, Lisa S.
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, James S.
    Lutsey, Pamela L.
    MAYO CLINIC PROCEEDINGS, 2023, 98 (07) : 985 - 996
  • [28] Real-World Evidence Demonstrating The Association Of SGLT2 Inhibitors With Reduced Cardiovascular Disease In Patients With Type 2 Diabetes
    Wang, Wendy
    Chen, Lin Y.
    Walker, Rob
    Chow, Lisa
    Norby, Faye L.
    Alonso, Alvaro
    Pankow, Jim S.
    Lutsey, Pamela L.
    CIRCULATION, 2022, 145
  • [29] Persistence and Adherence of Once-Weekly GLP-1 Receptor Agonists in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in a Real-World Setting
    Dunn, Tyler
    Zhu, Yong
    Gronroos, Noelle
    Xie, Lin
    Noone, Joshua
    Sargent, Andrew
    Yedigarova, Larisa
    Billings, Liana K.
    DIABETES, 2024, 73
  • [30] Trends and Gaps in Statin Use for Cardiovascular Disease Prevention in Type 2 Diabetes: A Real-World Study in Shanghai, China
    Jing, Renjie
    Yao, Huayan
    Yan, Qun
    Xue, Yanbin
    Sun, Wen
    Lu, Ping
    Zhang, Zizheng
    Xie, Rui
    Cui, Bin
    Feng, Bo
    ENDOCRINE PRACTICE, 2023, 29 (10) : 747 - 753
12345